Neurogene Ownership | Who Owns Neurogene?
Neurogene Ownership Summary
Neurogene is owned by 5.42% institutional investors, 8.54% insiders, and 86.04% retail investors. Samsara biocapital is the largest institutional shareholder, holding 8.16% of NGNE shares.
NGNE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Neurogene | 5.42% | 8.54% | 86.04% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Samsara biocapital | 1.72M | 8.16% | $29.76M |
| Rtw investments, lp | 1.36M | 6.47% | $23.61M |
| Redmile group | 1.30M | 6.17% | $22.51M |
| Casdin capital | 1.30M | 6.15% | $22.45M |
| Ecor1 capital | 1.27M | 6.04% | $22.03M |
| Baker bros. advisors lp | 991.69K | 4.71% | $17.19M |
| Blackrock funding, inc. /de | 951.10K | 4.52% | $16.48M |
| Toronto dominion bank | 681.34K | 3.24% | $11.81M |
| Vanguard group | 604.61K | 2.87% | $10.48M |
| Arrowmark colorado | 595.84K | 2.83% | $10.33M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 1.72M | 3.89% | $29.76M |
| Great point partners | 446.81K | 3.19% | $7.74M |
| Redmile group | 1.30M | 2.19% | $22.51M |
| Casdin capital | 1.30M | 1.87% | $22.45M |
| Ecor1 capital | 1.27M | 1.06% | $22.03M |
| Octagon capital advisors lp | 252.00K | 0.66% | $4.37M |
| Rtw investments, lp | 1.36M | 0.29% | $23.61M |
| Arrowmark colorado | 595.84K | 0.19% | $10.33M |
| Dafna capital management | 30.38K | 0.13% | $526.40K |
| Baker bros. advisors lp | 991.69K | 0.12% | $17.19M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jennison associates | 394.09K | 0.00% | 226.53K |
| Jane street group | 62.41K | 0.00% | 62.41K |
| Goldman sachs group | 72.80K | 0.00% | 55.51K |
| Trexquant investment lp | 39.48K | 0.01% | 39.48K |
| Exoduspoint capital management, lp | 32.52K | 0.01% | 32.52K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -446.88K |
| Commodore capital lp | - | - | -427.87K |
| Fmr | 115.55K | 0.00% | -352.93K |
| Price t rowe associates inc /md/ | - | - | -123.29K |
| Morgan stanley | 426.58K | 0.00% | -119.03K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jane street group | 62.41K | 0.00% | 62.41K | $1.08B |
| Trexquant investment lp | 39.48K | 0.01% | 39.48K | $684.24K |
| Exoduspoint capital management, lp | 32.52K | 0.01% | 32.52K | $563.59K |
| Quadrature capital | 16.83K | 0.00% | 16.83K | $291.97K |
| American century companies | 13.63K | 0.00% | 13.63K | $236.22K |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -5.00 |
| Raymond james financial | -8.00 |
| Corecap advisors | -11.00 |
| Coldstream capital management | -20.00 |
| Signaturefd | -22.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 26 | -67.50% | 1,140,405 | -92.30% | 5 | 0.11% | 13 | -64.86% | 7 | -74.07% |
| Jun 30, 2025 | 83 | -3.49% | 15,385,506 | 2.02% | 73 | 1.42% | 39 | -11.36% | 27 | 17.39% |
| Mar 31, 2025 | 88 | -3.30% | 16,456,922 | 3.74% | 78 | 0.90% | 45 | -22.41% | 23 | 43.75% |
| Dec 31, 2024 | 92 | 8.24% | 16,089,357 | 16.19% | 94 | 1.42% | 58 | 31.82% | 17 | -22.73% |
| Sep 30, 2024 | 85 | 28.79% | 13,847,659 | 4.39% | 81 | 1.33% | 44 | 4.76% | 22 | 57.14% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 14, 2025 | Cobb Stuart | Chief Scientific Officer | Sell | $103.00K |
| Mar 13, 2025 | Cvijic Christine Mikail | President and CFO | Sell | $76.25K |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | - | Buy | $406.80K |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | - | Buy | $516.83K |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | - | Buy | $280.99K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 1 |
| 2024 Q4 | 6 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
NGNE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools